TCROSS NEWS@GLOBAL

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide. #TCROSSGLOBAL

[TCROSS NEWS@GLOBAL @Tcross_Global]

The OPTION-STEMI trial demonstrated that among patients with STEMI and multivessel disease, the presence of heart failure at admission was associated with worse 1-year outcomes following immediate complete revascularization compared with ...(continue)
▼
https://t.co/cgpL2WBaPh

[TCROSS NEWS@GLOBAL @Tcross_Global]

Among patients with diabetes mellitus and left main (LM) and/or three-vessel disease, PCI was associated with a significantly higher 3-year risk of all-cause death, nonfatal MI, or stroke compared with CABG; however, intravascular ...(continue)
▼
https://t.co/M4zFw2k6Sa

[TCROSS NEWS@GLOBAL @Tcross_Global]

The NCDR CathPCI Registry demonstrated that the frequency of PCI for AMI caused by stent thrombosis remained unchanged in the United States between 2018 and 2023, and that PCI for stent thrombosis was associated with poor in-hospital ...(continue)
▼
https://t.co/kcrqec2H4x

[TCROSS NEWS@GLOBAL @Tcross_Global]

The iMODERN Trial demonstrated that among patients with STEMI and multivessel disease who underwent successful primary PCI, immediate iFR-guided PCI for non-culprit coronary lesions did not reduce the 3-year risk of all-cause death, ...(continue)
▼
https://t.co/3AULVRHfHM

[TCROSS NEWS@GLOBAL @Tcross_Global]

【EuroPCR 2026】The EMPERATRIZ Epic 36 Study demonstrated that OCT showed a strong correlation with IVUS for measuring minimum lumen area (MLA) in intermediate left main (LM) lesions, while IVUS measurements were approximately 0.6 mm² ...(continue)
▼
https://t.co/QknLah4QjE

[TCROSS NEWS@GLOBAL @Tcross_Global]

【EuroPCR 2026】The PECTUS-obs Trial demonstrated that among patients after myocardial infarction (MI), the presence of high-risk plaques in FFR-negative non-culprit lesions was associated with an increased risk of 5-year major adverse ...(continue)
▼
https://t.co/SLzwaYXXyP

[TCROSS NEWS@GLOBAL @Tcross_Global]

【EuroPCR 2026】The BILBO Study demonstrated that among patients with de novo coronary bifurcation lesions classified as Medina 0-0-1, treatment of the side branch with a DCB was associated with similar 2-year TLF rates and a lower risk ...(continue)
▼
https://t.co/v9FbG0bsw1

[TCROSS NEWS@GLOBAL @Tcross_Global]

The DCB-MVD Study demonstrated that more than 60% of patients with multivessel coronary artery disease could be successfully treated using a hybrid revascularization strategy combining DES and DCB, with short-term clinical outcomes ...(continue)
▼
https://t.co/VOvKAzACeH

[TCROSS NEWS@GLOBAL @Tcross_Global]

【EuroPCR 2026】The IVL-DCB Study demonstrated that PCI with intravascular lithotripsy (IVL) and DCB for severely calcified small vessel disease was associated with favorable early outcomes and evidence of positive vascular remodeling, ...(continue)
▼
https://t.co/gRUqzIXKl3

[TCROSS NEWS@GLOBAL @Tcross_Global]

【EuroPCR 2026】The SIROOP Registry demonstrated that OCT-guided PCI with DCB was safe and associated with favorable 1-year outcomes, according to a study presented by Dr. Firat Erdogan, Luzerner Kantonsspital, Switzerland, in the Hotline ...(continue)
▼
https://t.co/CZojocukkX

[TCROSS NEWS@GLOBAL @Tcross_Global]

【EuroPCR 2026】The ORACLE Trial demonstrated that among patients with severely calcified coronary lesions, orbital atherectomy was associated with less acute coronary microvascular dysfunction immediately after atherectomy compared with ...(continue)
▼
https://t.co/XAOPJpbs5D

[TCROSS NEWS@GLOBAL @Tcross_Global]

🔴Join Toyohashi Live 2026 online.

Experience complex PCI cases from Japan, including CTO, bifurcation, severely calcified lesions, and IVUS-guided decision-making.

📅 July 7–11, 2026
🌐 100% Online

Early bird registration until June 8:
https://t.co/94MxcmA0rA

[TCROSS NEWS@GLOBAL @Tcross_Global]

【EuroPCR 2026】The ICARE trial demonstrated that in patients with calcified coronary artery lesions, treatment with intravascular lithotripsy (IVL) was noninferior to rotational atherectomy (RA) with respect to post-procedural minimum ...(continue)
▼https://t.co/u0xoJxFLgQ

[TCROSS NEWS@GLOBAL @Tcross_Global]

【EuroPCR 2026】The ISAR-TEST 4 trial demonstrated that after 10 years of follow-up following PCI, biodegradable polymer sirolimus-eluting stents were associated with a lower risk of total TLR compared with early-generation durable polymer ...(continue)
▼https://t.co/4wJ9A48cUo

[TCROSS NEWS@GLOBAL @Tcross_Global]

【EuroPCR 2026】The ShortCUT IVUS substudy demonstrated that in coronary lesions with a calcium arc <360° or a calcium score of 0-1, there was no significant difference in the minimum stent area (MSA) at the site of maximum calcium ...(continue)
▼
https://t.co/lu0uoPuVl5

[TCROSS NEWS@GLOBAL @Tcross_Global]

The ROLLING STONE registry demonstrated that in PCI for calcified coronary lesions, procedural success rates were comparable between intravascular lithotripsy (IVL) and rotational/orbital atherectomy, whereas the 30-day incidence of MACE ...(continue)
▼https://t.co/SWm3PPXJ3w

[TCROSS NEWS@GLOBAL @Tcross_Global]

Clinical data from a large Australian registry demonstrated that patients undergoing PCI for ISR were older and had a higher burden of comorbidities compared with those undergoing PCI for de novo lesions, and although in-hospital mortality...(continue)
▼https://t.co/JsMsJeM53T

[TCROSS NEWS@GLOBAL @Tcross_Global]

Intravascular Lithotripsy (IVL) use was independently associated with favorable stent expansion among lesions with an OCT calcium score ≥3 despite an IVUS calcium score ≤2 in PCI for calcified lesions, Dr. Shun Kitajima and colleagues, ...(continue)
▼
https://t.co/CFMiu1Ujt6

[TCROSS NEWS@GLOBAL @Tcross_Global]

The TACTICS Registry demonstrated that among patients with STEMI who underwent OCT-guided PCI, those with calcified nodules (CN) had a significantly higher incidence of 1-year MACE ...(continue)
▼https://t.co/Xp92yC0KJn

[TCROSS NEWS@GLOBAL @Tcross_Global]

OCT-guided PCI showed comparable clinical outcomes to IVUS-guided PCI in patients with STEMI, Dr. Ikhtiyorjon Khamdamov and colleagues, Institute of Science Tokyo, reported in the February 15 issue of The American Journal of Cardiology.
▼
https://t.co/DtE1oYAT1l